# Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma

> **NCT00868192** · PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 38 (actual)

## Conditions studied

- Ovarian Carcinoma
- Primary Peritoneal Carcinoma

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT00868192
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868192, "Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00868192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*